Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151967 · ClinicalTrials.gov registry record · Phase 2
Lactobacillus Probiotic for Prevention of UTI
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT03151967 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 27 participants.
The verdict
NCT03151967, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this research is to see whether LACTIN-V (Lactobacillus crispatus CTV-05) is an effective method of preventing recurrent urinary tract infections (UTI's) and to learn the side effects of LACTIN-V. LACTIN-V is a vaginal applicator that contains Lactobacillus crispatus, an organism found naturally in the vaginas of healthy women. Lactobacillus bacteria are thought to help prevent other bacteria such as E. coli from causing UTI's. This is a double blind study comparing active product to a placebo (inactive vaginal applicator without any medicine).
Interventions
- DRUG Placebo
- DRUG Lactobacillus crispatus CTV-05
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-04-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03151967
The ClinicalTrials.gov registry entry for NCT03151967 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03151967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03151967 about?
NCT03151967 is a clinical study titled "Lactobacillus Probiotic for Prevention of UTI". The purpose of this research is to see whether LACTIN-V (Lactobacillus crispatus CTV-05) is an effective method of preventing recurrent urinary tract infections (UTI's) and to learn the side effects of LACTIN-V. LACTIN-V is a vaginal applicator that contains Lactobacillus crispatus, an organism foun...
What is the current status of trial NCT03151967?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2015-09. Estimated completion is 2017-04-05.
What interventions are being tested in trial NCT03151967?
The interventions under investigation include: Placebo (DRUG), Lactobacillus crispatus CTV-05 (DRUG).
Who is sponsoring clinical trial NCT03151967?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.